| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $222K | +56.6% |
| Cost of Revenue | $70K | -16.0% |
| Gross Profit | $152K | +160.0% |
| R&D Expense | $328K | -76.1% |
| SG&A Expense | $17.7M | -33.7% |
| Operating Income | -$18.8M | +77.6% |
| Income Tax | $670 | -95.6% |
| Net Income | -$6.7M | +86.0% |
| EPS (Basic) | -$0.16 | +91.5% |
| EPS (Diluted) | -$0.16 | +91.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $140K | +65.2% |
| Inventory | $9.7M | +29.4% |
| Current Assets | $15.6M | +4.6% |
| Total Assets | $28.2M | +33.8% |
| Current Liabilities | $31.8M | +58.0% |
| Total Liabilities | $38.0M | -0.4% |
| Stockholders' Equity | -$9.8M | +42.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$15.2M | +40.5% |
| Capital Expenditures | $8K | -82.2% |
| Investing Cash Flow | -$247K | +6.8% |
| Financing Cash Flow | $13.9M | -35.4% |
| Free Cash Flow | -$15.2M | +40.6% |